1. Главная
  2. Ресурсы
  3. Библиотечный поиск
Afatinib assecond-line treatmentin patients withrecurrent/metastaticsquamous cellcarcinoma of the headand neck Robert I. HaddadJ. GuigayUlrich Keilholz2019 год

Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial
статья из журнала

Страница публикацииПубликация в OpenAlex
Год издания: 2019
Авторы: Robert I. Haddad, J. Guigay, Ulrich Keilholz, Paul M. Clément, Jérôme Fayette, Luciano de Souza Viana, Frédéric Rolland, Didier Cupissol, Lionnel Geoffrois, Gabriela Kornek, Lisa Licitra, Bohuslav Melichar, Ulisses Ribaldo Nicolau, Daniel Rauch, Sylvie Zanetta-Devauges, Ezra E.W. Cohen, Jean-Pascal Machiels, Makoto Tahara, Jan B. Vermorken, Yuan Geng, Eleftherios Zografos, Thomas Gauler
Издательство: Elsevier BV
Источник: Oral Oncology
Ключевые слова: Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer-related gene regulation
Другие ссылки: Oral Oncology (HTML)
PubMed (HTML)